NZYM-B.CONZYM-B.COCPH
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank8
Year-over-Year Change
Year-over-year research & development expense growth
Percentile
P8
Near historical low
vs 5Y Ago
-1.3x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -14.19% |
| Q3 2025 | 707.64% |
| Q2 2025 | 2.14% |
| Q1 2025 | -50.94% |
| Q4 2024 | -73.17% |
| Q3 2024 | 12.39% |
| Q2 2024 | -0.01% |
| Q1 2024 | 38.44% |
| Q4 2023 | 13.67% |
| Q3 2023 | -10.49% |
| Q2 2023 | -0.39% |
| Q1 2023 | -3.36% |
| Q4 2022 | 12.63% |
| Q3 2022 | -4.62% |
| Q2 2022 | 1.01% |
| Q1 2022 | -3.71% |
| Q4 2021 | 17.70% |
| Q3 2021 | -12.83% |
| Q2 2021 | -11.37% |
| Q1 2021 | 6.23% |
| Q4 2020 | 11.11% |
| Q3 2020 | 1.49% |
| Q2 2020 | 2.17% |
| Q1 2020 | 3.84% |
| Q4 2019 | -14.81% |
| Q3 2019 | -4.59% |
| Q2 2019 | 19.00% |
| Q1 2019 | 2.00% |
| Q4 2018 | -10.20% |
| Q3 2018 | 7.53% |
| Q2 2018 | 3.10% |
| Q1 2018 | -8.52% |
| Q4 2017 | 12.05% |
| Q3 2017 | -7.76% |
| Q2 2017 | -5.17% |
| Q1 2017 | 5.89% |
| Q4 2016 | 9.95% |
| Q3 2016 | -5.26% |
| Q2 2016 | -9.16% |
| Q1 2016 | 11.31% |